Darunavir CBZ 1029

Prezista label

Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 1 dose
600 mg with 100 mg ritonaivr BID
Drug 1 effect

Darunavir: No significant change; Ritonavir cmax decreased 44%, AUC decreased 49%, Cmin decreased 56%

Drug 2
Drug 2 dose
200 mg BID
Drug 2 effect

Cmax increase 43%, AUC increase 45%, Cmin increase 54%

Clinical Effects

Increased carbamazepine effects

Management

Monitor anticonvulsant level and adjust accordingly. Consider carbamazepine dose reduction by 25-50%. Monitor antiviral efficacy

Import ID
1029